Tulsi Therapeutics, a biotech startup from Hyderabad, has reversed chronic liver failure in animal trials using Tulsi-28X, a first-in-class stem cell–exosome therapy. The innovation showed 100% survival and fibrosis reversal, setting the stage for human clinical trials.
“He is lying in the hospital surrounded by multiple machines but despite all that, he still greets us with a smile. I have watched him suffer due to his condition since birth but he has never stopped fighting. He gives me hope and I am proud to be his mother but if soon nothing is […]
